Gabapentin

Product NDC: 42192-608
11-digit product format: 421920608
Labeler code: 42192
Product ID: 42192-608_42b42328-c02f-5413-e063-6394a90ace67
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: SOLUTION
Route: ORAL
Labeler: Acella Pharmaceuticals, LLC
Application: ANDA076403
Marketing category: ANDA
Marketing start: 2012-10-01
Substance: GABAPENTIN
Active strength: 250 mg/5mL
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076403-001	GABAPENTIN	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA		2012-05-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A076403-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A076403-001	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	2012-05-01	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076403-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076403-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076403-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076403-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076403-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076403-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076403-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076403-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076403-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076403-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076403-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076403-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076403-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076403-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076403-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076403-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076403-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076403-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076403-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076403-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076403-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A076403-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A076403-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A076403-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A076403-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076403-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076403-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A076403-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A076403-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A076403-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A076403-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A076403-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A076403-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A076403-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A076403-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A076403-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076403-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A076403-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A076403-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A076403-001	AA	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Gabapentin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
283523	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42192-608-05	Gabapentin	5 mL in 1 CUP, UNIT-DOSE	SOLUTION	5	13
42192-608-06	Gabapentin	6 mL in 1 CUP, UNIT-DOSE	SOLUTION	6	13
42192-608-16	Gabapentin	470 mL in 1 BOTTLE	SOLUTION	470	13
42192-608-40	Gabapentin	6 mL in 1 CUP, UNIT-DOSE	SOLUTION	6	13
42192-608-40	Gabapentin	40 in 1 BOX	SOLUTION	40	13
42192-608-45	Gabapentin	5 mL in 1 CUP, UNIT-DOSE	SOLUTION	5	13
42192-608-45	Gabapentin	40 in 1 BOX	SOLUTION	40	13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42192-608-05	ML - Milliliter	42192-608	bf473aa3-aa15-4a8c-b6f6-ba3080ac465e	1	2021-06-02
42192-608-06	ML - Milliliter	42192-608	59c4be8d-d1a7-48d7-abe3-8ea63b642117	1	2020-03-10
42192-608-16	ML - Milliliter	42192-608	fb5393fc-3901-44da-933a-3777eccf4cd2	1	2013-02-13
42192-608-40	ML - Milliliter	42192-608	f2c872c1-bdd0-4150-83ad-06ebc534b383	1	2020-03-10
42192-608-45	ML - Milliliter	42192-608	e0c05083-0af4-4c2f-b2eb-3a171e060710	1	2021-06-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GABAPENTIN	ACTIVE INGREDIENT	6CW7F3G59X	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1
GABAPENTIN	ACTIVE MOIETY	6CW7F3G59X	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42192-608	GABAPENTIN SOLUTION [ACELLA PHARMACEUTICALS, LLC]	11	Current NDC, Legacy NDC, 7 package rows	20241011_3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	Acella Pharmaceuticals, LLC	3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	2025-11-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076403 application number: ANDA076403 ndc (product): 42192-608
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	5134369d-c7f6-4569-a425-d50e5a5d694f	2025-10-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076403 application number: ANDA076403
Gabapentin	GABAPENTIN	ATLANTIC BIOLOGICALS CORP.	5969f1a8-d6d5-4967-add5-4e2492354d7b	2025-05-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076403 application number: ANDA076403

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
283523	gabapentin 250 MG in 5 mL Oral Solution	PSN	5134369d-c7f6-4569-a425-d50e5a5d694f	102
283523	gabapentin 50 MG/ML Oral Solution	SCD	5134369d-c7f6-4569-a425-d50e5a5d694f	102
283523	gabapentin 250 MG per 5 ML Oral Solution	SY	5134369d-c7f6-4569-a425-d50e5a5d694f	102
283523	gabapentin 300 MG per 6 ML Oral Solution	SY	5134369d-c7f6-4569-a425-d50e5a5d694f	102
283523	gabapentin 500 MG per 10 ML Oral Solution	SY	5134369d-c7f6-4569-a425-d50e5a5d694f	102
283523	gabapentin 250 MG in 5 mL Oral Solution	PSN	3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	13
283523	gabapentin 50 MG/ML Oral Solution	SCD	3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	13
283523	gabapentin 250 MG per 5 ML Oral Solution	SY	3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	13
283523	gabapentin 300 MG per 6 ML Oral Solution	SY	3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	13
283523	gabapentin 500 MG per 10 ML Oral Solution	SY	3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2	13
283523	gabapentin 250 MG in 5 mL Oral Solution	PSN	5969f1a8-d6d5-4967-add5-4e2492354d7b	7
283523	gabapentin 50 MG/ML Oral Solution	SCD	5969f1a8-d6d5-4967-add5-4e2492354d7b	7
283523	gabapentin 250 MG per 5 ML Oral Solution	SY	5969f1a8-d6d5-4967-add5-4e2492354d7b	7
283523	gabapentin 300 MG per 6 ML Oral Solution	SY	5969f1a8-d6d5-4967-add5-4e2492354d7b	7
283523	gabapentin 500 MG per 10 ML Oral Solution	SY	5969f1a8-d6d5-4967-add5-4e2492354d7b	7
283523	gabapentin 250 MG in 5 mL Oral Solution	PSN	2b4d316c-1234-41d7-831d-645b3dd6e448	2
283523	gabapentin 50 MG/ML Oral Solution	SCD	2b4d316c-1234-41d7-831d-645b3dd6e448	2
283523	gabapentin 250 MG per 5 ML Oral Solution	SY	2b4d316c-1234-41d7-831d-645b3dd6e448	2
283523	gabapentin 300 MG per 6 ML Oral Solution	SY	2b4d316c-1234-41d7-831d-645b3dd6e448	2
283523	gabapentin 500 MG per 10 ML Oral Solution	SY	2b4d316c-1234-41d7-831d-645b3dd6e448	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
42192-608-05	42192060805	5 mL in 1 CUP, UNIT-DOSE (42192-608-05)	5 ml	2019-08-16	0000-00-00	No	No	Current
42192-608-06	42192060806	6 mL in 1 CUP, UNIT-DOSE (42192-608-06)	6 ml	2019-08-16	0000-00-00	No	No	Current
42192-608-16	42192060816	470 mL in 1 BOTTLE (42192-608-16)	470 ml	2012-10-01	0000-00-00	No	No	Current
42192-608-40	42192060840	40 CUP, UNIT-DOSE in 1 BOX (42192-608-40) / 6 mL in 1 CUP, UNIT-DOSE		2019-08-16	0000-00-00	No	No	Current
42192-608-45	42192060845	40 CUP, UNIT-DOSE in 1 BOX (42192-608-45) / 5 mL in 1 CUP, UNIT-DOSE		2021-05-05	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Gabapentin	Acella Pharmaceuticals, LLC	2025-11-03	HUMAN PRESCRIPTION DRUG LABEL	13
Gabapentin	Bryant Ranch Prepack	2025-10-29	HUMAN PRESCRIPTION DRUG LABEL	102
Gabapentin	REMEDYREPACK INC.	2025-09-19	HUMAN PRESCRIPTION DRUG LABEL	7
Gabapentin	ATLANTIC BIOLOGICALS CORP.	2025-05-27	HUMAN PRESCRIPTION DRUG LABEL	7
Gabapentin	Lohxa	2021-02-25	HUMAN PRESCRIPTION DRUG LABEL	2